Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,522.50
-80.00 (-3.07%)
Feb 13, 2026, 2:45 PM JST
2.94% (1Y)
| Market Cap | 588.07B -4.9% |
| Revenue (ttm) | 333.80B +18.3% |
| Net Income | 35.74B +31.1% |
| EPS | 155.28 +30.3% |
| Shares Out | 225.96M |
| PE Ratio | 16.76 |
| Forward PE | 17.66 |
| Dividend | 44.00 (1.70%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 957,600 |
| Average Volume | 566,275 |
| Open | 2,590.00 |
| Previous Close | 2,602.50 |
| Day's Range | 2,472.50 - 2,590.00 |
| 52-Week Range | 1,964.50 - 2,703.00 |
| Beta | -0.53 |
| RSI | 49.18 |
| Earnings Date | Feb 12, 2026 |